BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chetty S, Ramesh M, Singh-Pillay A, Soliman ME. Recent advancements in the development of anti-tuberculosis drugs. Bioorg Med Chem Lett 2017;27:370-86. [PMID: 28017531 DOI: 10.1016/j.bmcl.2016.11.084] [Cited by in Crossref: 67] [Cited by in F6Publishing: 49] [Article Influence: 11.2] [Reference Citation Analysis]
Number Citing Articles
1 Suaifan GA, Mohammed AA. Fluoroquinolones structural and medicinal developments (2013–2018): Where are we now? Bioorganic & Medicinal Chemistry 2019;27:3005-60. [DOI: 10.1016/j.bmc.2019.05.038] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 6.7] [Reference Citation Analysis]
2 Mehta P, Bothiraja C, Kadam S, Pawar A. Potential of dry powder inhalers for tuberculosis therapy: facts, fidelity and future. Artificial Cells, Nanomedicine, and Biotechnology 2018;46:S791-806. [DOI: 10.1080/21691401.2018.1513938] [Cited by in Crossref: 25] [Cited by in F6Publishing: 14] [Article Influence: 6.3] [Reference Citation Analysis]
3 Yan M, Xu L, Wang Y, Wan J, Liu T, Liu W, Wan Y, Zhang B, Wang R, Li Q. Opportunities and challenges of using five-membered ring compounds as promising antitubercular agents. Drug Dev Res 2020;81:402-18. [PMID: 31904877 DOI: 10.1002/ddr.21638] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 de Oliveira Viana J, Scotti MT, Scotti L. Molecular Docking Studies in Multitarget Antitubercular Drug Discovery. In: Roy K, editor. Multi-Target Drug Design Using Chem-Bioinformatic Approaches. New York: Springer; 2019. pp. 107-54. [DOI: 10.1007/7653_2018_28] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 Malasala S, Ahmad MN, Gour J, Shukla M, Kaul G, Akhir A, Gatadi S, Madhavi Y, Chopra S, Nanduri S. Synthesis, biological evaluation and molecular modelling insights of 2-arylquinazoline benzamide derivatives as anti-tubercular agents. Journal of Molecular Structure 2020;1218:128493. [DOI: 10.1016/j.molstruc.2020.128493] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
6 Dadda ADS, Rodrigues-junior VS, Carreño F, Petersen GO, Pinto AF, Dalberto PF, Sperotto ND, Pissinate K, Bizarro CV, Machado P, Campos MM, Costa TD, Santos DS, Basso LA. Preclinical pharmacokinetic profiling of IQG-607, a potential oral metallodrug to treat tuberculosis. European Journal of Pharmaceutical Sciences 2018;111:393-8. [DOI: 10.1016/j.ejps.2017.10.020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
7 Dawra S, Mandavdhare HS, Singh H, Prasad KK, Dutta U, Sharma V. Extra-abdominal involvement is associated with antitubercular therapy-related hepatitis in patients treated for abdominal tuberculosis. Clin Exp Hepatol 2019;5:60-4. [PMID: 30915408 DOI: 10.5114/ceh.2019.83158] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
8 Wang Y, Khan A, Chandra Kaushik A, Junaid M, Zhang X, Wei DQ. The systematic modeling studies and free energy calculations of the phenazine compounds as anti-tuberculosis agents. J Biomol Struct Dyn 2019;37:4051-69. [PMID: 30332914 DOI: 10.1080/07391102.2018.1537896] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
9 Malasala S, Gour J, Ahmad MN, Gatadi S, Shukla M, Kaul G, Dasgupta A, Madhavi YV, Chopra S, Nanduri S. Copper mediated one-pot synthesis of quinazolinones and exploration of piperazine linked quinazoline derivatives as anti-mycobacterial agents. RSC Adv 2020;10:43533-8. [DOI: 10.1039/d0ra08644d] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Shalini, Johansen MD, Kremer L, Kumar V. Variedly connected 1,8-naphthalimide-7-chloroquinoline conjugates: Synthesis, anti-mycobacterial and cytotoxic evaluation. Bioorganic Chemistry 2019;92:103241. [DOI: 10.1016/j.bioorg.2019.103241] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
11 Coghi PS, Zhu Y, Xie H, Hosmane NS, Zhang Y. Organoboron Compounds: Effective Antibacterial and Antiparasitic Agents. Molecules 2021;26:3309. [PMID: 34072937 DOI: 10.3390/molecules26113309] [Reference Citation Analysis]
12 Dehyab AS, Bakar MFA, AlOmar MK, Sabran SF. A review of medicinal plant of Middle East and North Africa (MENA) region as source in tuberculosis drug discovery. Saudi J Biol Sci 2020;27:2457-78. [PMID: 32884430 DOI: 10.1016/j.sjbs.2020.07.007] [Reference Citation Analysis]
13 Papageorgiou A, Foscolos A, Papanastasiou IP, Vlachou M, Siamidi A, Vocat A, Cole ST, Kellici TF, Mavromoustakos T, Tsotinis A. Synthesis, biology, computational studies and in vitro controlled release of new isoniazid-based adamantane derivatives. Future Medicinal Chemistry 2019;11:2779-802. [DOI: 10.4155/fmc-2019-0038] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Kumar G, Narayan R, Kapoor S. Chemical Tools for Illumination of Tuberculosis Biology, Virulence Mechanisms, and Diagnosis. J Med Chem 2020;63:15308-32. [PMID: 33307693 DOI: 10.1021/acs.jmedchem.0c01337] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Muluye AB, Kebamo S, Teklie T, Alemkere G. Poor treatment outcomes and its determinants among tuberculosis patients in selected health facilities in East Wollega, Western Ethiopia. PLoS One 2018;13:e0206227. [PMID: 30365530 DOI: 10.1371/journal.pone.0206227] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
16 Kushwaha SKS, Rai AK, Parveen H. Development & Pharmaceutical Characterization of Isoniazid Loaded Solid Lipid Nanoparticle Drug Delivery Approach. CDTH 2019;14:228-38. [DOI: 10.2174/1574885514666190103114200] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
17 Slavchev IM, Mitrev Y, Shivachev B, Valcheva V, Dogonadze M, Solovieva N, Vyazovaya A, Mokrousov I, Link W, Jiménez L, Cautain B, Mackenzie TA, Portugal I, Lopes F, Capela R, Perdigão J, Dobrikov GM. Synthesis, Characterization and Complex Evaluation of Antibacterial Activity and Cytotoxicity of New Arylmethylidene Ketones and Pyrimidines with Camphane Skeletons. ChemistrySelect 2022;7. [DOI: 10.1002/slct.202201339] [Reference Citation Analysis]
18 Chauhan A, Kumar M, Kumar A, Kanchan K. Comprehensive review on mechanism of action, resistance and evolution of antimycobacterial drugs. Life Sci 2021;274:119301. [PMID: 33675895 DOI: 10.1016/j.lfs.2021.119301] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
19 Yang H, Abouelhassan Y, Burch GM, Kallifidas D, Huang G, Yousaf H, Jin S, Luesch H, Huigens RW. A Highly Potent Class of Halogenated Phenazine Antibacterial and Biofilm-Eradicating Agents Accessed Through a Modular Wohl-Aue Synthesis. Sci Rep 2017;7:2003. [PMID: 28515440 DOI: 10.1038/s41598-017-01045-3] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
20 Shalini, Viljoen A, Kremer L, Kumar V. Alkylated/aminated nitroimidazoles and nitroimidazole-7-chloroquinoline conjugates: Synthesis and anti-mycobacterial evaluation. Bioorganic & Medicinal Chemistry Letters 2018;28:1309-12. [DOI: 10.1016/j.bmcl.2018.03.021] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
21 Dharra R, Radhakrishnan VS, Prasad T, Thakur Z, Cirillo JD, Sheoran A, Pandey AK, Kulharia M, Mehta PK. Evaluation of in silico designed inhibitors targeting MelF (Rv1936) against Mycobacterium marinum within macrophages. Sci Rep 2019;9:10084. [PMID: 31300732 DOI: 10.1038/s41598-019-46295-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
22 Pavić K, Rajić Z, Michnová H, Jampílek J, Perković I, Zorc B. Second generation of primaquine ureas and bis-ureas as potential antimycobacterial agents. Mol Divers 2019;23:657-67. [PMID: 30523579 DOI: 10.1007/s11030-018-9899-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
23 Charushin VN, Mochulskaya NN, Antipin FV, Kotovskaya SK, Nosova EV, Ezhikova MA, Kodess MI, Kravchenko MA. Synthesis and antimycobacterial evaluation of new (2-oxo- 2H -chromen-3-yl) substituted fluoroquinolones. Journal of Fluorine Chemistry 2018;208:15-23. [DOI: 10.1016/j.jfluchem.2018.01.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
24 Singh A, Viljoen A, Kremer L, Kumar V. Azide-alkyne cycloaddition en route to 4-aminoquinoline-ferrocenylchalcone conjugates: synthesis and anti-TB evaluation. Future Med Chem 2017;9:1701-8. [PMID: 28869400 DOI: 10.4155/fmc-2017-0098] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
25 Rani A, Viljoen A, Johansen MD, Kremer L, Kumar V. Synthesis, anti-mycobacterial and cytotoxic evaluation of substituted isoindoline-1,3-dione-4-aminoquinolines coupled via alkyl/amide linkers. RSC Adv 2019;9:8515-28. [DOI: 10.1039/c8ra10532d] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
26 Ghiraldi-Lopes LD, Campanerut-Sá PAZ, Evaristo GPC, Meneguello JE, Fiorini A, Baldin VP, de Souza EM, de Lima Scodro RB, Siqueira VLD, Cardoso RF. New insights on Ethambutol Targets in Mycobacterium tuberculosis. Infect Disord Drug Targets 2019;19:73-80. [PMID: 29366429 DOI: 10.2174/1871526518666180124140840] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
27 Vankar JK, Gupta A, Jadav JP, Nanjegowda SH, Gururaja GN. The thioamidation of gem-dibromoalkenes in an aqueous medium. Org Biomol Chem 2021;19:2473-80. [PMID: 33651057 DOI: 10.1039/d0ob02319a] [Reference Citation Analysis]
28 Krause M, Foks H, Ziembicka D, Augustynowicz-Kopeć E, Głogowska A, Korona-Głowniak I, Bojanowski K, Siluk D, Gobis K. 4-Substituted picolinohydrazonamides as a new class of potential antitubercular agents. Eur J Med Chem 2020;190:112106. [PMID: 32061963 DOI: 10.1016/j.ejmech.2020.112106] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Nosova EV, Lipunova GN, Charushin VN, Chupakhin ON. Synthesis and Biological Activity of 2-Amino- and 2-aryl (Heteryl) Substituted 1,3-Benzothiazin-4-ones. Mini Rev Med Chem 2019;19:999-1014. [PMID: 30324881 DOI: 10.2174/1389557518666181015151801] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
30 Rani A, Viljoen A, Sumanjit, Kremer L, Kumar V. Microwave-Assisted Highly Efficient Route to 4-Aminoquinoline-Phthalimide Conjugates: Synthesis and Anti-Tubercular Evaluation. ChemistrySelect 2017;2:10782-5. [DOI: 10.1002/slct.201702220] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
31 Kumar G, Krishna VS, Sriram D, Jachak SM. Synthesis of carbohydrazides and carboxamides as anti-tubercular agents. European Journal of Medicinal Chemistry 2018;156:871-84. [DOI: 10.1016/j.ejmech.2018.07.047] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
32 Mushtaque M, Avecilla F, Haque A, Yab Z, Rizvi MMA, Khan MS. Synthesis, structural and biological activity of N-substituted 2-methyl-4-/5-nitroimidazole derivatives. Journal of Molecular Structure 2019;1185:440-9. [DOI: 10.1016/j.molstruc.2019.02.101] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
33 Borbála Horváth L, Krátký M, Pflégr V, László Méhes E, Gyulai G, Kohut G, Babiczky Á, Biri-kovács B, Éva Baranyai Z, Vinšová J, Erika Bősze S. Host cell targeting of novel antimycobacterial 4-aminosalicylic acid derivatives with tuftsin carrier peptides. European Journal of Pharmaceutics and Biopharmaceutics 2022. [DOI: 10.1016/j.ejpb.2022.03.009] [Reference Citation Analysis]
34 Angelova VT, Pencheva T, Buyukliev R, Yovkova EK, Valkova I, Momekov G, Vulcheva V. Antimycobacterial Activity, In Silico ADME Evaluation, and Docking Study of Novel Thiazolidinedione and Imidazolidinone Conjugates. Russ J Bioorg Chem 2021;47:122-33. [DOI: 10.1134/s1068162021010027] [Reference Citation Analysis]
35 Anagani B, Singh J, Bassin JP, Besra GS, Benham C, Reddy TRK, Cox JAG, Goyal M. Identification and validation of the mode of action of the chalcone anti-mycobacterial compounds. Cell Surf 2020;6:100041. [PMID: 32743153 DOI: 10.1016/j.tcsw.2020.100041] [Reference Citation Analysis]
36 Spaggiari D, Desfontaine V, Cruchon S, Guinchard S, Vocat A, Blattes E, Pitteloud J, Ciullini L, Bardinet C, Ivanyuk A, Makarov V, Ryabova O, Buclin T, Cole ST, Decosterd LA. Development and validation of a multiplex UHPLC-MS/MS method for the determination of the investigational antibiotic against multi-resistant tuberculosis macozinone (PBTZ169) and five active metabolites in human plasma. PLoS One 2019;14:e0217139. [PMID: 31150423 DOI: 10.1371/journal.pone.0217139] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
37 Malasala S, Ahmad MN, Akunuri R, Shukla M, Kaul G, Dasgupta A, Madhavi YV, Chopra S, Nanduri S. Synthesis and evaluation of new quinazoline-benzimidazole hybrids as potent anti-microbial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis. Eur J Med Chem 2021;212:112996. [PMID: 33190958 DOI: 10.1016/j.ejmech.2020.112996] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
38 Abdel-maksoud MS, Ammar UM, El-gamal MI, Gamal El-din MM, Mersal KI, Ali EM, Yoo KH, Lee K, Oh C. Design, synthesis, and anticancer activity of imidazo[2,1-b]oxazole-based RAF kinase inhibitors. Bioorganic Chemistry 2019;93:103349. [DOI: 10.1016/j.bioorg.2019.103349] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
39 Kapp E, Joubert J, Sampson SL, Warner DF, Seldon R, Jordaan A, de Vos M, Sharma R, Malan SF. Antimycobacterial Activity, Synergism, and Mechanism of Action Evaluation of Novel Polycyclic Amines against Mycobacterium tuberculosis. Adv Pharmacol Pharm Sci 2021;2021:5583342. [PMID: 34240057 DOI: 10.1155/2021/5583342] [Reference Citation Analysis]
40 Fernandes GFS, Campos DL, Da Silva IC, Prates JLB, Pavan AR, Pavan FR, Dos Santos JL. Benzofuroxan Derivatives as Potent Agents against Multidrug-Resistant Mycobacterium tuberculosis. ChemMedChem 2021;16:1268-82. [PMID: 33410233 DOI: 10.1002/cmdc.202000899] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Nosova EV, Batanova OA, Lipunova GN, Kotovskaya SK, Slepukhin PA, Kravchenko MA, Charushin VN. SYNTHESIS AND ANTITUBERCULAR EVALUATION OF FLUORINATED 2-CYCLOALKYLIMINO SUBSTITUTED 1,3-BENZOTHIAZIN-4-ONES. Journal of Fluorine Chemistry 2019;220:69-77. [DOI: 10.1016/j.jfluchem.2019.02.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
42 Zheng J, Yuan Q, Zhou C, Huang W, Yu X. Mitochondrial stress response in drug-induced liver injury. Mol Biol Rep 2021;48:6949-58. [PMID: 34432218 DOI: 10.1007/s11033-021-06674-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Zinad DS, Mahal A, Al-amiery A. An Efficient Synthesis of Novel Imidazo-Aminopyridinyl Derivatives from 2-Chloro-4-cyanopyridine. Organic Preparations and Procedures International 2020;52:361-7. [DOI: 10.1080/00304948.2020.1767491] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Pavić K, Perković I, Pospíšilová Š, Machado M, Fontinha D, Prudêncio M, Jampilek J, Coffey A, Endersen L, Rimac H, Zorc B. Primaquine hybrids as promising antimycobacterial and antimalarial agents. Eur J Med Chem 2018;143:769-79. [PMID: 29220797 DOI: 10.1016/j.ejmech.2017.11.083] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 4.2] [Reference Citation Analysis]
45 Long Y, Wang D. Inhibition of Colon Cancer Cell Growth by Imidazole Through Activation of Apoptotic Pathway. Med Sci Monit 2019;25:7597-604. [PMID: 31597910 DOI: 10.12659/MSM.917779] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
46 Harale B, Kidwai S, Ojha D, Singh M, Chouhan DK, Singh R, Khedkar V, Rode AB. Synthesis and evaluation of antimycobacterial activity of riboflavin derivatives. Bioorg Med Chem Lett 2021;48:128236. [PMID: 34242760 DOI: 10.1016/j.bmcl.2021.128236] [Reference Citation Analysis]
47 Tolufashe GF, Sabe VT, Ibeji CU, Ntombela T, Govender T, Maguire GEM, Kruger HG, Lamichhane G, Honarparvar B. Structure and Function of L,D- and D,D-Transpeptidase Family Enzymes from Mycobacterium tuberculosis. Curr Med Chem 2020;27:3250-67. [PMID: 30501595 DOI: 10.2174/0929867326666181203150231] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
48 Cihan-Üstündağ G, Naesens L, Şatana D, Erköse-Genç G, Mataracı-Kara E, Çapan G. Design, synthesis, antitubercular and antiviral properties of new spirocyclic indole derivatives. Monatsh Chem 2019;150:1533-44. [PMID: 32214484 DOI: 10.1007/s00706-019-02457-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
49 Armstrong T, Lamont M, Lanne A, Alderwick LJ, Thomas NR. Inhibition of Mycobacterium tuberculosis InhA: Design, synthesis and evaluation of new di-triclosan derivatives. Bioorg Med Chem 2020;28:115744. [PMID: 33007556 DOI: 10.1016/j.bmc.2020.115744] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
50 Adeniji AA, Knoll KE, Loots DT. Potential anti-TB investigational compounds and drugs with repurposing potential in TB therapy: a conspectus. Appl Microbiol Biotechnol 2020;104:5633-62. [PMID: 32372202 DOI: 10.1007/s00253-020-10606-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
51 Haldar R, Narayanan SJ. A novel ensemble based recommendation approach using network based analysis for identification of effective drugs for Tuberculosis. Math Biosci Eng 2022;19:873-91. [PMID: 34903017 DOI: 10.3934/mbe.2022040] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 AlMatar M, AlMandeal H, Var I, Kayar B, Köksal F. New drugs for the treatment of Mycobacterium tuberculosis infection. Biomed Pharmacother 2017;91:546-58. [PMID: 28482292 DOI: 10.1016/j.biopha.2017.04.105] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
53 Barthod L, Lopez J, Curti C, Bornet C, Roche M, Montana M, Vanelle P. News on therapeutic management of MDR-tuberculosis: a literature review. Journal of Chemotherapy 2017;30:1-15. [DOI: 10.1080/1120009x.2017.1338845] [Cited by in Crossref: 6] [Article Influence: 1.2] [Reference Citation Analysis]
54 Fan YL, Jin XH, Huang ZP, Yu HF, Zeng ZG, Gao T, Feng LS. Recent advances of imidazole-containing derivatives as anti-tubercular agents. Eur J Med Chem 2018;150:347-65. [PMID: 29544148 DOI: 10.1016/j.ejmech.2018.03.016] [Cited by in Crossref: 71] [Cited by in F6Publishing: 49] [Article Influence: 17.8] [Reference Citation Analysis]
55 Wang W, Qin B, Wojdyla JA, Wang M, Gao X, Cui S. Structural characterization of free-state and product-state Mycobacterium tuberculosis methionyl-tRNA synthetase reveals an induced-fit ligand-recognition mechanism. IUCrJ 2018;5:478-90. [PMID: 30002848 DOI: 10.1107/S2052252518008217] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
56 Singh AK, Yadav P, Karaulia P, Singh VK, Gupta P, Puttrevu SK, Chauhan S, Bhatta RS, Tadigoppula N, Gupta UD, Chopra S, Dasgupta A. Biological evaluation of novel curcumin-pyrazole-mannich derivative active against drug-resistant Mycobacterium tuberculosis. Future Microbiol 2017;12:1349-62. [PMID: 29035081 DOI: 10.2217/fmb-2017-0054] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
57 Shalini, Johansen MD, Kremer L, Kumar V. Design, synthesis, anti‐mycobacterial and cytotoxic evaluation of C‐4 functionalized 1,8‐naphthalimide‐heterocyclic hydrazide conjugates. Chem Biol Drug Des 2019;94:1300-5. [DOI: 10.1111/cbdd.13503] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]